Skip to content

Multistrain probiotics lowered IBS symptom scores, with substantial uncertainty

A pooled analysis favored probiotics over placebo for overall symptom severity, while abdominal pain scores and IBS-specific quality of life did not improve significantly.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review found lower overall IBS symptom severity scores with multistrain probiotics than with placebo. Results varied greatly across studies, and some outcomes showed no statistically significant improvement. This abstract-based summary therefore supports a possible symptom benefit while leaving uncertainty about its consistency, its practical size and which probiotic mixtures contributed.

Keep in mind

The abstract reports very high variation between studies but does not explain which factors accounted for it. It also omits treatment durations, strain combinations and whether the average score difference was clinically meaningful.

THE NUMBERS, WITH CONTEXT

What researchers found

-43.66 points

Mean difference in total IBS symptom severity score

Probiotics versus placebo; 95% confidence interval: -65.89 to -21.44. Treatment duration is not reported in the abstract.

Eur J Gastroenterol Hepatol, 2026 · Original source ↓

What the score captures

The main measure was the IBS symptom severity score, which summarizes several symptom domains. A lower total score favored probiotics, but the reported average does not show whether every individual symptom changed.

Why separate outcomes matter

Several symptom subscores improved, including bloating and bowel habit satisfaction. The quality-of-life subscore also improved, while the separate IBS-specific quality-of-life measure did not show a statistically significant change. These are distinct reported outcomes.

CHECK THE ORIGINAL

The original publication

Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes.

Anwar DFF, Salma ZN, Oktaviani SD et al.
Eur J Gastroenterol Hepatol · 2026

PubMed ID
41433106
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.